Abliva Future Growth
Future criteria checks 0/6
Abliva's revenue and earnings are forecast to decline at 118.4% and 20.2% per annum respectively while EPS is expected to decline by 8.7% per annum.
Key information
-20.2%
Earnings growth rate
-8.7%
EPS growth rate
Biotechs earnings growth | 44.6% |
Revenue growth rate | -118.4% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 16 Dec 2024 |
Recent future growth updates
No updates
Recent updates
Is Abliva (STO:ABLI) In A Good Position To Invest In Growth?
Oct 02Abliva (STO:ABLI) Is In A Strong Position To Grow Its Business
Dec 18Here's Why We're A Bit Worried About Abliva's (STO:ABLI) Cash Burn Situation
Aug 24Is Abliva (STO:ABLI) In A Good Position To Invest In Growth?
Aug 21We're Keeping An Eye On Abliva's (STO:ABLI) Cash Burn Rate
Oct 13Is Abliva (STO:ABLI) In A Good Position To Invest In Growth?
Mar 22How Much Is Abliva AB (publ) (STO:ABLI) Paying Its CEO?
Dec 06Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | N/A | -134 | -127 | -126 | 1 |
12/31/2025 | N/A | -121 | -115 | -114 | 1 |
12/31/2024 | N/A | -89 | -82 | -81 | 1 |
9/30/2024 | 0 | -89 | -91 | -89 | N/A |
6/30/2024 | 0 | -102 | -58 | -57 | N/A |
3/31/2024 | 0 | -98 | -28 | -27 | N/A |
12/31/2023 | 0 | -96 | -9 | -8 | N/A |
9/30/2023 | N/A | -88 | -15 | -15 | N/A |
6/30/2023 | 0 | -80 | -115 | -114 | N/A |
3/31/2023 | 0 | -79 | -145 | -144 | N/A |
12/31/2022 | 0 | -85 | -160 | -160 | N/A |
9/30/2022 | 0 | -105 | -195 | -194 | N/A |
6/30/2022 | 0 | -114 | -121 | -120 | N/A |
3/31/2022 | 0 | -124 | -124 | -123 | N/A |
12/31/2021 | 0 | -123 | -115 | -114 | N/A |
9/30/2021 | 2 | -100 | -86 | -84 | N/A |
6/30/2021 | 2 | -75 | -69 | -68 | N/A |
3/31/2021 | 2 | -65 | -54 | -53 | N/A |
12/31/2020 | 2 | -60 | -69 | -68 | N/A |
9/30/2020 | 1 | -74 | -79 | -77 | N/A |
6/30/2020 | 3 | -79 | -84 | -82 | N/A |
3/31/2020 | 4 | -80 | -83 | -80 | N/A |
12/31/2019 | 4 | -77 | -75 | -72 | N/A |
9/30/2019 | 4 | -65 | -67 | -63 | N/A |
6/30/2019 | 2 | -64 | -61 | -57 | N/A |
3/31/2019 | 2 | -69 | -75 | -72 | N/A |
12/31/2018 | 2 | -68 | -68 | -64 | N/A |
9/30/2018 | 2 | -68 | -66 | -62 | N/A |
6/30/2018 | 2 | -66 | N/A | -64 | N/A |
3/31/2018 | 0 | -63 | N/A | -57 | N/A |
12/31/2017 | 0 | -67 | N/A | -58 | N/A |
9/30/2017 | 0 | -66 | N/A | -60 | N/A |
6/30/2017 | 0 | -87 | N/A | -55 | N/A |
3/31/2017 | 0 | -76 | N/A | -55 | N/A |
12/31/2016 | 0 | -70 | N/A | -57 | N/A |
9/30/2016 | N/A | -63 | N/A | -62 | N/A |
6/30/2016 | N/A | -83 | N/A | -66 | N/A |
3/31/2016 | 3 | -87 | N/A | -59 | N/A |
12/31/2015 | 3 | -90 | N/A | -67 | N/A |
9/30/2015 | 4 | -100 | N/A | -52 | N/A |
6/30/2015 | 11 | -49 | N/A | -50 | N/A |
3/31/2015 | 8 | -47 | N/A | -49 | N/A |
12/31/2014 | 8 | -43 | N/A | -44 | N/A |
9/30/2014 | 7 | -35 | N/A | -47 | N/A |
6/30/2014 | 1 | -38 | N/A | -41 | N/A |
3/31/2014 | 6 | -27 | N/A | -31 | N/A |
12/31/2013 | 7 | -22 | N/A | -19 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ABLI is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: ABLI is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: ABLI is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: ABLI is forecast to have no revenue next year.
High Growth Revenue: ABLI is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if ABLI's Return on Equity is forecast to be high in 3 years time
Discover growth companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/23 06:10 |
End of Day Share Price | 2024/12/20 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Abliva AB (publ) is covered by 4 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Patrik Ling | DNB Markets |
Jonas Peciulis | Edison Investment Research |
Ludvig Svensson | Penser Access |